{"id":1753,"date":"2023-01-29T07:07:14","date_gmt":"2023-01-29T07:07:14","guid":{"rendered":"https:\/\/www.junshipharma.com\/?p=1753"},"modified":"2023-01-31T07:11:59","modified_gmt":"2023-01-31T07:11:59","slug":"%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9%e5%ae%a3%e5%b8%83%e5%8f%a3%e6%9c%8d%e6%8a%97%e6%96%b0%e5%86%a0%e7%97%85%e6%af%92%e8%8d%af%e7%89%a9%e6%b0%91%e5%be%97%e7%bb%b4%ef%bc%88vv116%ef%bc%89%e8%8e%b7","status":"publish","type":"post","link":"https:\/\/www.junshipharma.com\/%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9%e5%ae%a3%e5%b8%83%e5%8f%a3%e6%9c%8d%e6%8a%97%e6%96%b0%e5%86%a0%e7%97%85%e6%af%92%e8%8d%af%e7%89%a9%e6%b0%91%e5%be%97%e7%bb%b4%ef%bc%88vv116%ef%bc%89%e8%8e%b7\/","title":{"rendered":"\u541b\u5b9e\u751f\u7269\u5ba3\u5e03\u53e3\u670d\u6297\u65b0\u51a0\u75c5\u6bd2\u836f\u7269\u6c11\u5f97\u7ef4\u00ae\uff08VV116\uff09\u83b7\u5f97\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u6279\u51c6"},"content":{"rendered":"\n
\u5317\u4eac\u65f6\u95f42023\u5e741\u670829\u65e5\uff0c\u541b\u5b9e\u751f\u7269\uff081877.HK\uff0c688180.SH\uff09\u5ba3\u5e03\uff0c\u516c\u53f8\u65d7\u4e0b\u7684\u53e3\u670d\u6838\u82f7\u7c7b\u6297\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\uff08SARS-CoV-2\uff09\u836f\u7269\u6c11\u5f97\u7ef4\u00ae<\/sup>\uff08\u6c22\u6eb4\u9178\u6c18\u745e\u7c73\u5fb7\u97e6\u7247\uff0c\u4ea7\u54c1\u4ee3\u53f7\uff1aVV116\/JT001\uff09\u83b7\u5f97\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u8f7b\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\uff08COVID-19\uff09\u7684\u6210\u5e74\u60a3\u8005\u3002<\/p>\n\n\n\n VV116\u662f\u4e00\u6b3e\u65b0\u578b\u53e3\u670d\u6838\u82f7\u7c7b\u6297\u75c5\u6bd2\u836f\u7269\uff0c\u80fd\u591f\u4ee5\u6838\u82f7\u4e09\u78f7\u9178\u5f62\u5f0f\u975e\u5171\u4ef7\u7ed3\u5408\u5230\u65b0\u51a0\u75c5\u6bd2RNA\u4f9d\u8d56\u6027RNA\u805a\u5408\u9176\uff08RdRp\uff09\u7684\u6d3b\u6027\u4e2d\u5fc3\uff0c\u76f4\u63a5\u6291\u5236\u75c5\u6bd2RdRp\u7684\u6d3b\u6027\uff0c\u963b\u65ad\u75c5\u6bd2\u7684\u590d\u5236\uff0c\u4ece\u800c\u53d1\u6325\u6297\u75c5\u6bd2\u7684\u4f5c\u7528\u3002\u4e34\u5e8a\u524d\u7814\u7a76\u663e\u793a\uff0cVV116\u5bf9\u5305\u62ec\u5965\u5bc6\u514b\u620e\u5728\u5185\u7684\u65b0\u51a0\u75c5\u6bd2\u539f\u59cb\u682a\u548c\u7a81\u53d8\u682a\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u75c5\u6bd2\u4f5c\u7528\uff0c\u4e14\u65e0\u9057\u4f20\u6bd2\u6027\u3002<\/p>\n\n\n\n VV116\u7531\u4e2d\u56fd\u79d1\u5b66\u9662\u4e0a\u6d77\u836f\u7269\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u6b66\u6c49\u75c5\u6bd2\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u65b0\u7586\u7406\u5316\u6280\u672f\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u4e2d\u4e9a\u836f\u7269\u7814\u53d1\u4e2d\u5fc3\/\u4e2d\u4e4c\u533b\u836f\u79d1\u6280\u57ce\uff08\u79d1\u6280\u90e8\u201c\u4e00\u5e26\u4e00\u8def\u201d\u8054\u5408\u5b9e\u9a8c\u5ba4\uff09\u3001\u4e34\u6e2f\u5b9e\u9a8c\u5ba4\u3001\u82cf\u5dde\u65fa\u5c71\u65fa\u6c34\u751f\u7269\u533b\u836f\u6709\u9650\u516c\u53f8\uff08\u65fa\u5c71\u65fa\u6c34\uff09\u548c\u541b\u5b9e\u751f\u7269\u5171\u540c\u7814\u53d1\u3002<\/p>\n\n\n\n \u6b64\u6b21\u83b7\u6279\u4e3b\u8981\u57fa\u4e8e\u4e00\u9879\u591a\u4e2d\u5fc3\u3001\u53cc\u76f2\u3001\u968f\u673a\u3001\u5b89\u6170\u5242\u5bf9\u7167\u3001III\u671f\u4e34\u5e8a\u7814\u7a76\uff08NCT05582629\uff09\uff0c\u65e8\u5728\u8bc4\u4ef7VV116\u5728\u4f34\u6216\u4e0d\u4f34\u6709\u8fdb\u5c55\u4e3a\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u4e2d\u5ea6COVID-19\u60a3\u8005\u4e2d\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u3002\u7814\u7a76\u7684\u4e3b\u8981\u7ec8\u70b9\u662f\u4ece\u9996\u6b21\u7ed9\u836f\u81f3\u6301\u7eed\u4e34\u5e8a\u75c7\u72b6\u6d88\u5931\u7684\u65f6\u95f4\uff0c\u6b21\u8981\u7ec8\u70b9\u5305\u62ec\u81f3\u6301\u7eed\u4e34\u5e8a\u75c7\u72b6\u7f13\u89e3\u7684\u65f6\u95f4\u3001\u622a\u81f3\u7b2c28\u5929\u53d1\u751f\u75be\u75c5\u8fdb\u5c55\u7684\u60a3\u8005\u6bd4\u4f8b\u3001SARS-CoV-2\u6838\u9178\u548c\u75c5\u6bd2\u8f7d\u91cf\u7684\u53d8\u5316\u3001\u5b89\u5168\u6027\u7b49\u3002<\/p>\n\n\n\n \u7814\u7a76\u7ed3\u679c\u663e\u793a\uff0c\u81f3\u671f\u4e2d\u5206\u6790\u7684\u6570\u636e\u622a\u6b62\u65e5\uff0c\u57281,277\u4f8b\u968f\u673a\u5e76\u63a5\u53d7\u6cbb\u7597\u7684\u53d7\u8bd5\u8005\u4e2d\uff0cVV116\u76f8\u8f83\u5b89\u6170\u5242\uff0c\u4e3b\u8981\u7ec8\u70b9\u4ece\u9996\u6b21\u7ed9\u836f\u81f3\u6301\u7eed\u4e34\u5e8a\u75c7\u72b6\u6d88\u5931\uff0811\u9879COVID-19\u76f8\u5173\u4e34\u5e8a\u75c7\u72b6\u8bc4\u5206=0\u4e14\u6301\u7eed2\u5929\uff09\u65f6\u95f4\u663e\u8457\u7f29\u77ed\uff0c\u4e2d\u4f4d\u65f6\u95f4\u5dee\u8fbe2\u5929\uff1b\u81f3\u6301\u7eed\u4e34\u5e8a\u75c7\u72b6\u7f13\u89e3\u65f6\u95f4\u663e\u8457\u7f29\u77ed\uff0c\u75c5\u6bd2\u8f7d\u91cf\u8f83\u57fa\u7ebf\u53d8\u5316\u7b49\u75c5\u6bd2\u5b66\u6307\u6807\u5747\u4f18\u4e8e\u5b89\u6170\u5242\u7ec4\u3002<\/p>\n\n\n\n \u8be5\u7814\u7a76\u7684\u4e3b\u8981\u7814\u7a76\u8005\u3001\u6d59\u6c5f\u5927\u5b66\u4f20\u67d3\u75c5\u8bca\u6cbb\u56fd\u5bb6\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u4e3b\u4efb\u674e\u5170\u5a1f\u9662\u58eb<\/strong>\u8868\u793a\uff1a\u201c\u4ece2022\u5e7410\u670821\u65e5\u9996\u4f8b\u60a3\u8005\u7b5b\u9009\u5f00\u59cb\uff0c\u5168\u56fd30\u591a\u5bb6\u4e2d\u5fc3\u514b\u670d\u4e86\u91cd\u91cd\u56f0\u96be\uff0c\u5728\u79ef\u6781\u6551\u6cbb\u60a3\u8005\u3001\u9632\u91cd\u75c7\u3001\u964d\u6b7b\u4ea1\u7387\u7684\u540c\u65f6\uff0c\u5728\u4e0d\u52303\u4e2a\u6708\u7684\u65f6\u95f4\u5185\uff0c\u5feb\u901f\u3001\u9ad8\u6548\u5730\u5b8c\u6210\u4e861300\u591a\u4f8b\u8f7b\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u8005\u7684\u5165\u7ec4\u3002\u76ee\u524d\u672c\u7814\u7a76\u5df2\u7ecf\u5b8c\u6210\u65b9\u6848\u9884\u8bbe\u7684\u671f\u4e2d\u5206\u6790\uff0c\u7ed3\u679c\u663e\u793a\uff1a\u5728\u6709\u6548\u6027\u65b9\u9762\uff0c\u4e0e\u5b89\u6170\u5242\u7ec4\u76f8\u6bd4\uff0c\u63a5\u53d7VV116\u6cbb\u7597\u7684\u60a3\u8005\uff0c\u81f3\u6301\u7eed\u4e34\u5e8a\u75c7\u72b6\u6d88\u5931\u7684\u65f6\u95f4\u548c\u4e34\u5e8a\u75c7\u72b6\u7f13\u89e3\u7684\u65f6\u95f4\u5747\u663e\u8457\u7f29\u77ed\uff0c\u65b0\u51a0\u75c5\u6bd2Ct\u503c\u7684\u4e0a\u5347\u901f\u5ea6\u53ca\u75c5\u6bd2\u8f7d\u91cf\u7684\u4e0b\u964d\u901f\u5ea6\u4e5f\u660e\u663e\u5feb\u4e8e\u5b89\u6170\u5242\u7ec4\uff1b\u5728\u5b89\u5168\u6027\u65b9\u9762\uff0cVV116\u6cbb\u7597\u7ec4\u5728\u6cbb\u7597\u671f\u95f4\u4e0d\u826f\u4e8b\u4ef6\u7684\u53d1\u751f\u7387\u4f4e\uff0c\u4e0e\u5b89\u6170\u5242\u7ec4\u76f8\u5f53\u3002VV116\u4ee5\u5176\u826f\u597d\u7684\u7597\u6548\u4e0e\u5b89\u5168\u6027\u8868\u73b0\uff0c\u6709\u671b\u6210\u4e3a\u6cbb\u7597\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\uff08COVID-19\uff09\u7684\u4e00\u7ebf\u836f\u7269\u4e4b\u4e00\uff0c\u800c\u4e14\u8f7b\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u666e\u901a\u60a3\u8005\u548c\u5b58\u5728\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u60a3\u8005\u5747\u53ef\u83b7\u76ca\u3002\u76ee\u524d\u5168\u56fd\u5404\u5730\u65b0\u51a0\u75ab\u60c5\u60c5\u51b5\u4f9d\u7136\u6bd4\u8f83\u4e25\u5cfb\uff0cVV116\u7684\u4e0a\u5e02\u4e00\u5b9a\u80fd\u8ba9\u66f4\u591a\u7684\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u8005\u5f97\u5230\u6709\u6548\u7684\u6297\u75c5\u6bd2\u6cbb\u7597\uff0c\u964d\u4f4e\u75ab\u60c5\u4f20\u64ad\u98ce\u9669\uff0c\u5e76\u5728\u4e00\u5b9a\u7a0b\u5ea6\u4e0a\u51cf\u5c11\u91cd\u75c7\u7684\u53d1\u751f\uff0c\u4e3a\u6253\u8d62\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u533b\u7597\u6551\u6cbb\u653b\u575a\u6218\uff0c\u6700\u5927\u7a0b\u5ea6\u4fdd\u62a4\u4eba\u6c11\u7fa4\u4f17\u751f\u547d\u5b89\u5168\u548c\u8eab\u4f53\u5065\u5eb7\uff0c\u8d21\u732e\u91cd\u8981\u529b\u91cf\u3002\u201d<\/p>\n\n\n\n \u4e0a\u6d77\u836f\u7269\u7814\u7a76\u6240\u674e\u4f73\u6240\u957f<\/strong>\u8868\u793a\uff1a\u201c\u9762\u5bf9\u4e25\u5cfb\u7684\u75ab\u60c5\u5f62\u52bf\uff0c\u4e0a\u6d77\u836f\u7269\u6240\u5feb\u901f\u54cd\u5e94\u56fd\u5bb6\u7d27\u6025\u836f\u7269\u7814\u53d1\u9700\u6c42\uff0c\u5728\u848b\u534e\u826f\u9662\u58eb\u7684\u9886\u5bfc\u4e0b\uff0c\u7b2c\u4e00\u65f6\u95f4\u6210\u7acb\u6297\u75ab\u8054\u5408\u653b\u5173\u56e2\u961f\uff0c\u591c\u4ee5\u7ee7\u65e5\u3001\u534f\u4f5c\u594b\u6597\uff0c\u5feb\u901f\u83b7\u5f97\u9776\u5411\u65b0\u51a0\u75c5\u6bd2RdRp\u7684\u5019\u9009\u65b0\u836f\u5206\u5b50VV116\uff0c\u4e0e\u5404\u65b9\u5408\u4f5c\u4f19\u4f34\u7d27\u5bc6\u534f\u4f5c\uff0c\u79ef\u6781\u4fc3\u8fdb\u79d1\u7814\u6210\u679c\u8f6c\u79fb\u8f6c\u5316\uff0c\u4e89\u5206\u593a\u79d2\u5730\u4e0e\u75ab\u60c5\u8d5b\u8dd1\uff0c\u5168\u529b\u63a8\u8fdb\u65b0\u836f\u4e34\u5e8a\u7814\u7a76\u548c\u4e0a\u5e02\u5de5\u4f5c\uff0c\u53d1\u6325\u65b0\u836f\u521b\u5236\u56fd\u5bb6\u6218\u7565\u79d1\u6280\u529b\u91cf\u7684\u91cd\u8981\u4f5c\u7528\u3002\u201d<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n \u5173\u4e8e\u6c11\u5f97\u7ef4\u00ae<\/sup>\uff08\u6c22\u6eb4\u9178\u6c18\u745e\u7c73\u5fb7\u97e6\u7247\uff0cVV116\/JT001\uff09<\/strong><\/p>\n\n\n\n VV116\u662f\u4e00\u6b3e\u53e3\u670d\u6838\u82f7\u7c7b\u836f\u7269\uff0c\u53ef\u6291\u5236SARS-CoV-2\u590d\u5236\u3002\u4e34\u5e8a\u524d\u836f\u6548\u5b66\u7814\u7a76\u663e\u793a\uff0cVV116\u5728\u4f53\u5916\u5bf9\u5305\u62ec\u5965\u5bc6\u514b\u620e\u5728\u5185\u7684\u65b0\u51a0\u75c5\u6bd2\u539f\u59cb\u682a\u548c\u7a81\u53d8\u682a\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u75c5\u6bd2\u4f5c\u7528\uff1b\u5728\u5c0f\u9f20\u6a21\u578b\u4e0a\uff0c\u4f4e\u5242\u91cf\u7684VV116\u5c31\u53ef\u5c06\u80ba\u90e8\u75c5\u6bd2\u6ef4\u5ea6\u964d\u4f4e\u81f3\u68c0\u6d4b\u9650\u4ee5\u4e0b\uff0c\u53ef\u663e\u8457\u6539\u5584\u80ba\u7ec4\u7ec7\u75c5\u7406\u53d8\u5316\uff0c\u8868\u73b0\u51fa\u8f83\u5f3a\u7684\u6297\u75c5\u6bd2\u529f\u6548\u3002\u4e34\u5e8a\u524d\u7684\u836f\u4ee3\u52a8\u529b\u5b66\u7b49\u7814\u7a76\u7ed3\u679c\u663e\u793a\uff0cVV116\u5177\u6709\u5f88\u9ad8\u7684\u53e3\u670d\u751f\u7269\u5229\u7528\u5ea6\uff0c\u5176\u53e3\u670d\u5438\u6536\u540e\uff0c\u8fc5\u901f\u4ee3\u8c22\u4e3a\u6bcd\u4f53\u6838\u82f7\uff0c\u5e76\u5728\u4f53\u5185\u7ec4\u7ec7\u5e7f\u6cdb\u5206\u5e03\u3002<\/p>\n\n\n\n VV116\u7531\u4e2d\u56fd\u79d1\u5b66\u9662\u4e0a\u6d77\u836f\u7269\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u6b66\u6c49\u75c5\u6bd2\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u65b0\u7586\u7406\u5316\u6280\u672f\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u4e2d\u4e9a\u836f\u7269\u7814\u53d1\u4e2d\u5fc3\/\u4e2d\u4e4c\u533b\u836f\u79d1\u6280\u57ce\uff08\u79d1\u6280\u90e8\u201c\u4e00\u5e26\u4e00\u8def\u201d\u8054\u5408\u5b9e\u9a8c\u5ba4\uff09\u3001\u4e34\u6e2f\u5b9e\u9a8c\u5ba4\u3001\u82cf\u5dde\u65fa\u5c71\u65fa\u6c34\u751f\u7269\u533b\u836f\u6709\u9650\u516c\u53f8\uff08\u65fa\u5c71\u65fa\u6c34\uff09\u548c\u541b\u5b9e\u751f\u7269\u5171\u540c\u7814\u53d1\u3002\u541b\u5b9e\u751f\u7269\u4e0e\u65fa\u5c71\u65fa\u6c34\u5171\u540c\u627f\u62c5\u8be5\u836f\u7269\u5728\u5168\u7403\u5c42\u9762\u7684\u4e34\u5e8a\u5f00\u53d1\u548c\u4ea7\u4e1a\u5316\u5de5\u4f5c\uff0c\u5408\u4f5c\u533a\u57df\u4e3a\u9664\u4e2d\u4e9a\u4e94\u56fd\u3001\u4fc4\u7f57\u65af\u3001\u5317\u975e\u3001\u4e2d\u4e1c\u56db\u4e2a\u533a\u57df\u5916\u7684\u5168\u7403\u8303\u56f4\u3002<\/p>\n\n\n\n \u541b\u5b9e\u751f\u7269\u4e0e\u65fa\u5c71\u65fa\u6c34\u5df2\u5728\u4e2d\u56fd\u5065\u5eb7\u53d7\u8bd5\u8005\u4e2d\u5b8c\u6210\u4e863\u9879I\u671f\u4e34\u5e8a\u7814\u7a76[1]<\/sup>\uff0c\u5e76\u5728\u4e2d\u56fd\u4f34\u6709\u8fdb\u5c55\u4e3a\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u4e2d\u5ea6COVID-19\u60a3\u8005\u4e2d\u5b8c\u62101\u9879III\u671f\u4e34\u5e8a\u7814\u7a76[2]<\/sup>\uff08NCT05341609\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u5206\u522b\u53d1\u8868\u4e8eActa Pharmacologica Sinica<\/em>\u548c\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\uff08The New England Journal of Medicine<\/em>\uff09\u3002\u53e6\uff0c1\u9879\u5728\u4f34\u6216\u4e0d\u4f34\u6709\u8fdb\u5c55\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u4e2d\u5ea6COVID-19\u60a3\u8005\u4e2d\u5f00\u5c55\u7684III\u671f\u7814\u7a76\u5df2\u5b8c\u6210\u65b9\u6848\u9884\u8bbe\u7684\u671f\u4e2d\u5206\u6790\uff0c\u8fbe\u6210\u65b9\u6848\u9884\u8bbe\u89c4\u5b9a\u7684\u4e3b\u8981\u6709\u6548\u6027\u7ec8\u70b9\u3002<\/p>\n\n\n\n 2021\u5e7412\u6708\uff0cVV116\u5728\u4e4c\u5179\u522b\u514b\u65af\u5766\u83b7\u5f97\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u4e2d\/\u91cd\u5ea6COVID-19\u60a3\u8005\u3002<\/p>\n\n\n\n 2023\u5e741\u6708\uff0cVV116\u5728\u4e2d\u56fd\u83b7\u5f97\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u8f7b\u4e2d\u5ea6COVID-19\u7684\u6210\u5e74\u60a3\u8005\u3002<\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" \u5317\u4eac\u65f6\u95f42023\u5e741\u670829\u65e5\uff0c\u541b\u5b9e\u751f\u7269\uff081877.HK\uff0c688180.SH\uff09\u5ba3\u5e03\uff0c\u516c\u53f8\u65d7\u4e0b\u7684\u53e3\u670d\u6838\u82f7\u7c7b\u6297\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\uff08SARS-CoV-2\uff09\u836f\u7269\u6c11\u5f97\u7ef4\u00ae\uff08\u6c22\u6eb4\u9178\u6c18\u745e\u7c73\u5fb7\u97e6\u7247\uff0c\u4ea7\u54c1\u4ee3\u53f7\uff1aVV116\/JT001\uff09\u83b7\u5f97\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u8f7b\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\uff08COVID-19\uff09\u7684\u6210\u5e74\u60a3\u8005\u3002<\/p>\n","protected":false},"author":3,"featured_media":1285,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1"],"yoast_head":"\n1. <\/em>\u672c\u6750\u6599\u65e8\u5728\u4f20\u9012\u524d\u6cbf\u4fe1\u606f\uff0c\u65e0\u610f\u5411\u60a8\u505a\u4efb\u4f55\u4ea7\u54c1\u7684\u63a8\u5e7f\uff0c\u4e0d\u4f5c\u4e3a\u4e34\u5e8a\u7528\u836f\u6307\u5bfc\u3002<\/em><\/h6>\n\n\n\n
2. \u82e5\u60a8\u60f3\u4e86\u89e3\u5177\u4f53\u75be\u75c5\u8bca\u7597\u4fe1\u606f\uff0c\u8bf7\u9075\u4ece\u533b\u7597\u536b\u751f\u4e13\u4e1a\u4eba\u58eb\u7684\u610f\u89c1\u4e0e\u6307\u5bfc\u3002<\/em><\/h6>\n\n\n\n\n\n
\u3010\u53c2\u8003\u6587\u732e\u3011<\/h5>\n\n\n\n
[1] Qian, Hj., et al. Acta Pharmacol Sin (2022).<\/h5>\n\n\n\n
[2] Cao Z, Gao W, Bao H, et al. VV116 versus Nirmatrelvir\u2013Ritonavir for Oral Treatment of Covid-19. N Engl J Med. DOI: 10.1056\/NEJMoa2208822.<\/h5>\n\n\n\n\n\n